Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis

被引:4
|
作者
Inoue, KI
Takano, H
Yanagisawa, R
Yoshikawa, T
机构
[1] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan
[2] Kyoto Prefectural Univ Med, Kyoto, Japan
关键词
D O I
10.1016/S0012-3692(15)36047-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:413 / 414
页数:2
相关论文
共 50 条
  • [21] Tumor necrosis factor-α antagonist use and cancer in patients with rheumatoid arthritis
    Setoguchi, Soko
    Solomon, Daniel H.
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Glynn, Robert J.
    Francis Cook, E.
    Carney, Greg
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S19 - S19
  • [22] Blockade of tumour necrosis factor-α in rheumatoid arthritis:: effects on components of rheumatoid cachexia
    Metsios, G. S.
    Stavropoulos-Kalinoglou, A.
    Douglas, K. M. J.
    Koutedakis, Y.
    Nevill, A. M.
    Panoulas, V. F.
    Kita, M.
    Kitas, G. D.
    RHEUMATOLOGY, 2007, 46 (12) : 1824 - 1827
  • [23] Tumor necrosis factor inhibitors: New options for treating rheumatoid arthritis
    Moreland, LW
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (09): : 686 - 690
  • [24] Inhibitors of tumor necrosis factor: New treatment options for rheumatoid arthritis
    Moreland, LW
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1999, 66 (06) : 367 - 374
  • [25] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Nicoletta Luciano
    Elisa Barone
    Suraj Timilsina
    M. Eric Gershwin
    Carlo Selmi
    Clinical Reviews in Allergy & Immunology, 2023, 65 : 403 - 419
  • [26] Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
    Agarwal, Sandeep K.
    Glass, Roberta J.
    Shadick, Nancy A.
    Coblyn, Jonathan S.
    Anderson, Ronald J.
    Maher, Nancy E.
    Weinblatt, Michael E.
    Solomon, Daniel H.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1737 - 1744
  • [27] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Luciano, Nicoletta
    Barone, Elisa
    Timilsina, Suraj
    Gershwin, M. Eric
    Selmi, Carlo
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 403 - 419
  • [28] Perforating folliculitis associated with tumour necrosis factor-α inhibitors administered for rheumatoid arthritis
    Gilaberte, Y.
    Coscojuela, C.
    Vazquez, C.
    Rosello, R.
    Vera, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) : 368 - 371
  • [29] Rheumatoid arthritis and tumor necrosis factor α
    Abe, T
    Takeuchi, T
    AUTOIMMUNITY, 2001, 34 (04) : 291 - 303
  • [30] Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors
    Regina Rendas-Baum
    Gene V Wallenstein
    Tamas Koncz
    Mark Kosinski
    Min Yang
    John Bradley
    Samuel H Zwillich
    Arthritis Research & Therapy, 13